Pancreatic Cancer Research

ResearcherLeidos Biomedical Research Inc. (United States)Active in the last 2 years

Lizhi Zhang

Matched on ORCID iD 0000-0001-5829-9234; OpenAlex author ID A5100663891. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
69
Papers, trials and grants by year

2013: 1 paper · 2014: 4 papers · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: 1 paper · 2020: 2 papers · 2021: 1 paper · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 1 paper

Papers 15

  1. Heterogeneity of Tertiary Lymphoid Structures and Plasma Cells in PDAC with and Without Lymph Node Metastasis. First author DOI 10.3390/cancers17182949↗
  2. Coxsackievirus and adenovirus receptor expression facilitates enteroviral infections to drive the development of pancreatic cancer. Co-author DOI 10.1038/s41467-024-55043-x↗
  3. Pancreatic Cancer is More Frequently Early Stage at Diagnosis in Surgically Resected Intraductal Papillary Mucinous Neoplasms With Preoperative Surveillance. Co-author DOI 10.1016/j.gastha.2022.07.004↗
  4. Anticachectic regulator analysis reveals Perp-dependent antitumorigenic properties of 3-methyladenine in pancreatic cancer. Co-author DOI 10.1172/jci.insight.153842↗
  5. Development of a MicroRNA Signature Predictive of Recurrence and Survival in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3390/cancers13205168↗
  6. Endoscopic ultrasound may be used to deliver gene expression signatures using digital mRNA detection methods to immunophenotype pancreatic ductal adenocarcinom… Last author DOI 10.1016/j.pan.2019.12.002↗
  7. KRAS Controls Pancreatic Cancer Cell Lipid Metabolism and Invasive Potential through the Lipase HSL. Co-author DOI 10.1158/0008-5472.can-20-1255↗
  8. High-Grade Dysplasia in Resected Main-Duct Intraductal Papillary Mucinous Neoplasm (MD-IPMN) is Associated with an Increased Risk of Subsequent Pancreatic Canc… Co-author DOI 10.1038/s41395-018-0403-2↗
  9. Integrated Genomic Characterization of Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1016/j.ccell.2017.07.007↗
  10. Fructose-1,6-bisphosphatase Inhibits ERK Activation and Bypasses Gemcitabine Resistance in Pancreatic Cancer by Blocking IQGAP1-MAPK Interaction. Co-author DOI 10.1158/0008-5472.can-16-3143↗
  11. Transcriptome analysis of pancreatic cancer reveals a tumor suppressor function for HNF1A. Co-author DOI 10.1093/carcin/bgu193↗
  12. CLPTM1L promotes growth and enhances aneuploidy in pancreatic cancer cells. Co-author DOI 10.1158/0008-5472.can-13-3176↗
  13. Tumor cell-derived MMP3 orchestrates Rac1b and tissue alterations that promote pancreatic adenocarcinoma. Co-author DOI 10.1158/1541-7786.mcr-13-0557-t↗
  14. Clinical characteristics and overall survival in patients with anaplastic pancreatic cancer. Co-author DOI 10.1177/000313481408000218↗
  15. Rare ALK expression but no ALK rearrangement in pancreatic ductal adenocarcinoma and neuroendocrine tumors. Last author DOI 10.1097/mpa.0b013e3182847bd0↗

Closest collaborators

The 25 strongest of 69 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hailong Chen · 1 shared paper, 2025 · strength 0.42
  2. Mengfei Wang · 1 shared paper, 2025 · strength 0.42
  3. Rondell Patrell Graham · 4 shared papers, 2013–2022 · strength 0.35
  4. Ferga C. Gleeson · 3 shared papers, 2019–2022 · strength 0.32
  5. Michael J. Levy · 3 shared papers, 2019–2022 · strength 0.32
  6. Gina Lynn Razidlo · 2 shared papers, 2020–2022 · strength 0.30
  7. Michael L. Kendrick · 2 shared papers, 2019–2022 · strength 0.20
  8. Randall K. Pearson · 2 shared papers, 2019–2022 · strength 0.20
  9. Suresh T. Chari · 2 shared papers, 2019–2022 · strength 0.20
  10. Shounak Majumder · 2 shared papers, 2019–2022 · strength 0.20
  11. Santhi Swaroop Vege · 2 shared papers, 2019–2022 · strength 0.20
  12. E. Aubrey Thompson · 1 shared paper, 2024 · strength 0.18
  13. Heike R. Döppler · 1 shared paper, 2024 · strength 0.18
  14. Ligia I. Bastea · 1 shared paper, 2024 · strength 0.18
  15. Veethika Pandey · 1 shared paper, 2024 · strength 0.18
  16. Alicia K. Fleming Martinez · 1 shared paper, 2024 · strength 0.18
  17. Peter Störz · 1 shared paper, 2024 · strength 0.18
  18. Michael Anthony Hollingsworth · 1 shared paper, 2024 · strength 0.18
  19. Paul M. Grandgenett · 1 shared paper, 2024 · strength 0.18
  20. Cody N. Rozeveld · 1 shared paper, 2020 · strength 0.16
  21. Paige C. Arneson‐Wissink · 1 shared paper, 2022 · strength 0.14
  22. Aneesha Dasgupta · 1 shared paper, 2022 · strength 0.14
  23. Jason D. Doles · 1 shared paper, 2022 · strength 0.14
  24. Martín E. Fernández-Zapico · 1 shared paper, 2022 · strength 0.14
  25. Jaime de la Fuente · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.